Free Trial

Cibus Q4 2022 Earnings Report

Cibus logo
$3.68 -0.07 (-1.87%)
(As of 01:24 PM ET)

Cibus EPS Results

Actual EPS
-$3.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cibus Revenue Results

Actual Revenue
$0.04 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cibus Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

This drone stock is setting up to transform medical supply delivery (Ad)

Drone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.

Click here to see how a new partnership could catapult this drone suppliers' growth

Cibus Earnings Headlines

DeFi Coin on Verge of Breakout!
[FREE BOOK] Can You Make a Fortune in Crypto with $50? Get started now before the market takes off!
Cibus Enhances Board with Appointment of August Moretti
See More Cibus Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cibus? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cibus and other key companies, straight to your email.

About Cibus

Cibus (NASDAQ:CBUS), a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.

View Cibus Profile

More Earnings Resources from MarketBeat

Upcoming Earnings